Leber Laura

Track

Insider profile

Leber Laura's trades of Genomic Health Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
464.43
Quantity 77,934 +27.2%
Value US$3,832,758
Transaction date
Planned sale
Price
71.71
Quantity 39,235 -9.3%
Value US$4,700,060
Transaction date
Planned sale
Price
419.24
Quantity 34,437 -18.6%
Value US$2,574,042
Transaction date
Planned sale
Price
85.47
Quantity 1,067 -4.7%
Value US$91,192
Transaction date
Planned sale
Price
83.50
Quantity 3,271 -13.6%
Value US$273,119
Transaction date
Planned sale
Price
82.74
Quantity 15,479 -39.1%
Value US$1,280,705
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2019-10-21 2019-10-17
PlS Planned sale
77,934 +27.2%
464.43
US$3,832,758 		77,934 +27.2% 464.43 US$3,832,758
2019-02-22 2019-02-21
PlS Planned sale
39,235 -9.3%
71.71
US$4,700,060 		39,235 -9.3% 71.71 US$4,700,060
2019-02-22 2019-02-21
PlS Planned sale
34,437 -18.6%
419.24
US$2,574,042 		34,437 -18.6% 419.24 US$2,574,042
2019-02-22 2019-02-21
PlS Planned sale
1,067 -4.7%
85.47
US$91,192 		1,067 -4.7% 85.47 US$91,192
2019-02-22 2019-02-20
PlS Planned sale
3,271 -13.6%
83.50
US$273,119 		3,271 -13.6% 83.50 US$273,119
2019-02-22 2019-02-20
PlS Planned sale
15,479 -39.1%
82.74
US$1,280,705 		15,479 -39.1% 82.74 US$1,280,705